Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-07-13

FDA Approved: TPOXX — Original Application (SIGA Technologies, Inc.)

View source ↗

Summary

FDA granted original approval for TPOXX (tecovirimat monohydrate) from SIGA Technologies for the treatment of smallpox due to variola virus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TPOXX (tecovirimat monohydrate)

Snippet

ORIG AP for TPOXX (TECOVIRIMAT MONOHYDRATE)